Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer
NCT01080248Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in pancreatic adenocarcinoma (PDAC), sponsored by Washington University School of Medicine. Started Aug 2010; status: terminated.
02
Drugs
pazopanib
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01080248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01080248.